Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition

SelectedCancer MetabolismCRISPR/Mouse Models of Cancer
Written by Gabriel de Souza

Ding H, Chen Z, Wu K, Huang SM, Wu WL, LeBoeuf SE, Pillai RG, Rabinowitz JD, Papagiannakopoulos T.

Sci Adv. 2021 Nov 19;7(47):eabk1023. doi: 10.1126/sciadv.abk1023. Epub 2021 Nov 17.

Read more

Gabriel de Souza
Previous

Rlf-Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer
Next

Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment